|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM023937858 |
| 003 |
DE-627 |
| 005 |
20231221092359.0 |
| 007 |
tu |
| 008 |
231221s1985 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed24n0080.xml
|
| 035 |
|
|
|a (DE-627)NLM023937858
|
| 035 |
|
|
|a (NLM)2412423
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Horii, A
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy
|
| 264 |
|
1 |
|c 1985
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 30.09.1985
|
| 500 |
|
|
|a Date Revised 19.11.2015
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Cernilton was given clinically to 30 patients with benign prostatic hypertrophy. Cernilton was given orally at least for 12 weeks at a daily dose of 6 tablets in three divided doses. The overall clinical efficacy on subjective symptoms was 80%, and that on objective signs, 43%. During the administration period of Cernilton, no serious untoward effects were observed in either the clinical or laboratory findings. It is, therefore, suggested that, from the clinical point of view, Cernilton is a useful and safe drug in the treatment of benign prostatic hypertrophy
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Plant Extracts
|2 NLM
|
| 650 |
|
7 |
|a cernilton
|2 NLM
|
| 650 |
|
7 |
|a 8054-43-1
|2 NLM
|
| 700 |
1 |
|
|a Iwai, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Maekawa, M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tsujita, M
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 31(1985), 4 vom: 15. Apr., Seite 739-46
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:31
|g year:1985
|g number:4
|g day:15
|g month:04
|g pages:739-46
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 31
|j 1985
|e 4
|b 15
|c 04
|h 739-46
|